Phibro Animal Health Reports FY2026 Results and FY2027 Guidance

What Happened

• On August 26, 2026, Phibro Animal Health Corporation announced its operating results for the fourth quarter and fiscal year ended June 30, 2026, and released financial guidance for the fiscal year ending June 30, 2027. The information was provided via a press release furnished as Exhibit 99.1 to the Form 8‑K. The filing notes the information is being furnished (not “filed”) under the Exchange Act.

Key Details

• Date of announcement: August 26, 2026.
• Periods covered: fourth quarter and fiscal year ended June 30, 2026.
• Forward-looking information: financial guidance provided for fiscal year ending June 30, 2027.
• Filing references: Item 2.02 (Results of Operations and Financial Condition) and Exhibit 99.1 (press release).

Why It Matters

• Earnings results and company guidance are primary drivers of investor expectations—these items can affect analyst estimates, consensus revenue/earnings forecasts, and share price reactions.
• Retail investors should review the furnished press release (Exhibit 99.1) and subsequent SEC filings for the detailed revenue, profit, and guidance figures to assess performance and outlook.